Dr. Walter John Urba MD, PHD
Oncologist | Medical Oncology
4805 Ne Glisan St 6n40 Portland OR, 97213About
Dr. Walter Urba is an oncologist practicing in Portland, OR. Dr. Urba specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Urba manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Univ of Miami Sch of Med, Miami Fl 1981
University of Miami Leonard M. Miller School of Medicine 1981
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Immunization of metastatic breast cancer patients with CD80-modified breast cancer cells and GM-CSF.
- Examining the immune response in sentinel lymph nodes of mice and men.
- Abrogation of the hematological and biological activities of the interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein PIXY321 by neutralizing anti-PIXY321 antibodies in cancer patients receiving high-dose carboplatin.
- Mutated cytochrome b as a determinant of a new monoclonal antibody (H8.98) on renal carcinoma cell lines recognized by a Vgamma3Vdelta1(+) T-cell clone.
- Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
- Engagement of the OX-40 receptor in vivo enhances antitumor immunity.
- Isolation of genes overexpressed in freshly isolated breast cancer specimens.
- Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
- Spontaneous mammary carcinomas fail to induce an immune response in syngeneic FVBN202 neu transgenic mice.
- Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
- Chemokine receptor desensitization in tumor-bearing mice.
- Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy.
- Role of C chemokine lymphotactin in mediating recruitment of antigen-specific CD62L(lo) cells in vitro and in vivo.
- Immunological and molecular analysis of the sentinel lymph node: a potential approach to predict outcome, tailor therapy, and optimize parameters for tumor vaccine development.
- Are all hypotheses generated before data analysis prospective?
Clinical Trials
- Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma
- Neoadjuvant Immunoradiotherapy in Head & Neck Cancer
- TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
- Immunoscore in Rectal Cancer
Treatments
- Melanoma
- Skin Cancer
Dr. Walter John Urba MD, PHD's Practice location
Dr. Walter John Urba MD, PHD's reviews
Write ReviewPatient Experience with Dr. Urba
Recommended Articles
- What is Cancer Immunotherapy?
Immunotherapy, also referred as biological therapy, is a special type of cancer treatment aimed at boosting the body's immune system to help fight cancer cells. Cancer cells don’t die normally as other cells do, and divide uncontrollably with each cell making more of itself like a copy machine...
- What is Testicular Cancer: Get the Facts
Testicular cancer is a malignancy that affects the testes, which are the sex glands in men that are responsible for secreting the male sex hormone testosterone and for producing sperm cells that fertilize female eggs to kick start a pregnancy.Prevalence of testicular cancerIn the United States,...
- Do Breast Cancer Patients Receive Too Much Radiation?
When people hear the word “cancer” they naturally become very fearful for their future. Cancer is a terrifying diagnosis to receive and can leave patients feeling uncertain, desperate, confused, yet also motivated to do whatever is in their power to get fight it. This fear can lead to situations...
- NHS Strikes Deal for Cutting Edge Cancer Treatment for Adults with Lymphoma
The National Health Service (NHS) is the publicly-funded national healthcare system for England. Together with the biopharmaceutical company, Gilead Sciences, the two organizations have reached an agreement to provide CAR T-cell therapy to patients with a type of cancer that has, sadly, left them...
- Survivors and Soulmates
“Every 3 minutes, a woman learns she has breast cancer. She is a mother, a daughter, a sister, a friend. I am that woman. Every 13 minutes, a woman dies of the disease. I will not be that woman. I will survive.” This is a message by writer and fashion stylist Meredith Gray in the documentary...
- What Primary Care Providers Need to Know About Ovarian Cancer
In the United States, there will be 22,440 women diagnosed with ovarian cancer in 2017 and over half of those cases will be fatal, according to the American Cancer Society. For women, ovarian cancer is the fifth leading cause of cancer deaths. And a woman’s risk of developing ovarian cancer in her...
Nearby Providers
- Dr. Edward Weilie Soo M.D.5050 Ne Hoyt St Portland OR 97213
- Dr. Eric Daniel Bernstein M.D.4805 Ne Glisan St Portland OR 97213
- Dr. Robert Charles Lufkin D.O.4805 Ne Glisan St Portland OR 97213
- Dr. Todd Shane Crocenzi M.D.4805 Ne Glisan St Portland OR 97213
- Dr. Rachel Elizabeth Sanborn MD4805 Ne Glisan Portland OR 97213
- Dr. Bruce Wilson Dana M.D.5050 Ne Hoyt St Portland OR 97213